193 related articles for article (PubMed ID: 37074831)
1. Will MDMA-assisted psychotherapy become a breakthrough in treatment-resistant post-traumatic stress disorder? A critical narrative review.
Szafoni S; Więckiewicz G; Pudlo R; Gorczyca P; Piegza M
Psychiatr Pol; 2022 Aug; 56(4):823-836. PubMed ID: 37074831
[TBL] [Abstract][Full Text] [Related]
2. MDMA-assisted psychotherapy for treatment of PTSD: study design and rationale for phase 3 trials based on pooled analysis of six phase 2 randomized controlled trials.
Mithoefer MC; Feduccia AA; Jerome L; Mithoefer A; Wagner M; Walsh Z; Hamilton S; Yazar-Klosinski B; Emerson A; Doblin R
Psychopharmacology (Berl); 2019 Sep; 236(9):2735-2745. PubMed ID: 31065731
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic effect of increased openness: Investigating mechanism of action in MDMA-assisted psychotherapy.
Wagner MT; Mithoefer MC; Mithoefer AT; MacAulay RK; Jerome L; Yazar-Klosinski B; Doblin R
J Psychopharmacol; 2017 Aug; 31(8):967-974. PubMed ID: 28635375
[TBL] [Abstract][Full Text] [Related]
4. Psilocybin and MDMA for the treatment of trauma-related psychopathology.
Bird CIV; Modlin NL; Rucker JJH
Int Rev Psychiatry; 2021 May; 33(3):229-249. PubMed ID: 34121583
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for posttraumatic stress disorder: A systematic review and meta-analysis.
Bahji A; Forsyth A; Groll D; Hawken ER
Prog Neuropsychopharmacol Biol Psychiatry; 2020 Jan; 96():109735. PubMed ID: 31437480
[TBL] [Abstract][Full Text] [Related]
6. MDMA-assisted psychotherapy for PTSD: Are memory reconsolidation and fear extinction underlying mechanisms?
Feduccia AA; Mithoefer MC
Prog Neuropsychopharmacol Biol Psychiatry; 2018 Jun; 84(Pt A):221-228. PubMed ID: 29524515
[TBL] [Abstract][Full Text] [Related]
7. 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for post-traumatic stress disorder in military veterans, firefighters, and police officers: a randomised, double-blind, dose-response, phase 2 clinical trial.
Mithoefer MC; Mithoefer AT; Feduccia AA; Jerome L; Wagner M; Wymer J; Holland J; Hamilton S; Yazar-Klosinski B; Emerson A; Doblin R
Lancet Psychiatry; 2018 Jun; 5(6):486-497. PubMed ID: 29728331
[TBL] [Abstract][Full Text] [Related]
8. Potential Psychiatric Uses for MDMA.
Yazar-Klosinski BB; Mithoefer MC
Clin Pharmacol Ther; 2017 Feb; 101(2):194-196. PubMed ID: 27859039
[TBL] [Abstract][Full Text] [Related]
9. Long-term follow-up outcomes of MDMA-assisted psychotherapy for treatment of PTSD: a longitudinal pooled analysis of six phase 2 trials.
Jerome L; Feduccia AA; Wang JB; Hamilton S; Yazar-Klosinski B; Emerson A; Mithoefer MC; Doblin R
Psychopharmacology (Berl); 2020 Aug; 237(8):2485-2497. PubMed ID: 32500209
[TBL] [Abstract][Full Text] [Related]
10. A comparison of MDMA-assisted psychotherapy to non-assisted psychotherapy in treatment-resistant PTSD: A systematic review and meta-analysis.
Illingworth BJ; Lewis DJ; Lambarth AT; Stocking K; Duffy JM; Jelen LA; Rucker JJ
J Psychopharmacol; 2021 May; 35(5):501-511. PubMed ID: 33345689
[TBL] [Abstract][Full Text] [Related]
11. MDMA and PTSD treatment: "PTSD: From novel pathophysiology to innovative therapeutics".
Sessa B
Neurosci Lett; 2017 May; 649():176-180. PubMed ID: 27394687
[TBL] [Abstract][Full Text] [Related]
12. Preliminary evidence for the importance of therapeutic alliance in MDMA-assisted psychotherapy for posttraumatic stress disorder.
Zeifman RJ; Kettner H; Ross S; Weiss B; Mithoefer MC; Mithoefer AT; Wagner AC
Eur J Psychotraumatol; 2024; 15(1):2297536. PubMed ID: 38174611
[TBL] [Abstract][Full Text] [Related]
13. MDMA-Assisted Psychotherapy for Treatment of Posttraumatic Stress Disorder: A Systematic Review With Meta-Analysis.
Smith KW; Sicignano DJ; Hernandez AV; White CM
J Clin Pharmacol; 2022 Apr; 62(4):463-471. PubMed ID: 34708874
[TBL] [Abstract][Full Text] [Related]
14. Discontinuation of medications classified as reuptake inhibitors affects treatment response of MDMA-assisted psychotherapy.
Feduccia AA; Jerome L; Mithoefer MC; Holland J
Psychopharmacology (Berl); 2021 Feb; 238(2):581-588. PubMed ID: 33221932
[TBL] [Abstract][Full Text] [Related]
15. Progress and promise for the MDMA drug development program.
Feduccia AA; Holland J; Mithoefer MC
Psychopharmacology (Berl); 2018 Feb; 235(2):561-571. PubMed ID: 29152674
[TBL] [Abstract][Full Text] [Related]
16. Psychedelic Therapy: A Primer for Primary Care Clinicians-3,4-Methylenedioxy-methamphetamine (MDMA).
Shinozuka K; Tabaac BJ; Arenas A; Beutler BD; Cherian K; Evans VD; Fasano C; Muir OS
Am J Ther; 2024 Mar-Apr 01; 31(2):e141-e154. PubMed ID: 38518271
[TBL] [Abstract][Full Text] [Related]
17. [MDMA-assisted therapy for PTSD].
Thorarinsdottir H; Gudmundsdottir B; Sigurdsson E
Laeknabladid; 2024 May; 110(5):254-261. PubMed ID: 38713560
[TBL] [Abstract][Full Text] [Related]
18. The Psychopharmacology of ±3,4 Methylenedioxymethamphetamine and its Role in the Treatment of Posttraumatic Stress Disorder.
Amoroso T
J Psychoactive Drugs; 2015; 47(5):337-44. PubMed ID: 26579955
[TBL] [Abstract][Full Text] [Related]
19. MDMA to Treat PTSD in Adults.
Latimer D; Stocker MD; Sayers K; Green J; Kaye AM; Abd-Elsayed A; Cornett EM; Kaye AD; Varrassi G; Viswanath O; Urits I
Psychopharmacol Bull; 2021 Jun; 51(3):125-149. PubMed ID: 34421149
[TBL] [Abstract][Full Text] [Related]
20. MDMA-Based Psychotherapy in Treatment-Resistant Post-Traumatic Stress Disorder (PTSD): A Brief Narrative Overview of Current Evidence.
Riaz K; Suneel S; Hamza Bin Abdul Malik M; Kashif T; Ullah I; Waris A; Di Nicola M; Mazza M; Sani G; Martinotti G; De Berardis D
Diseases; 2023 Nov; 11(4):. PubMed ID: 37987270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
